Primary Objectives
• To evaluate thyroid nodule volume changes over time in participants undergoing RFA as part of clinical care
Secondary Objectives
* To establish the health-related quality of life among participants undergoing with ultrasound guided RFA.
* To evaluate the sonographic features of thyroid nodules over time following ultrasound guided RFA.
* To assess adverse events rates following ultrasound guided RFA.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Eligibility Criteria
1. Participants scheduled to undergo ultrasound-guided RFA for the following conditions: benign thyroid nodules, indeterminate thyroid nodules, low-risk DTC, and recurrent PTC
2. Participant is over 18 years and is either not a surgical candidate or has declined surgery.
3. Capable and willing to provide written informed consent
4. Participant has one of the following diagnoses:
* Biopsy-proven benign thyroid nodules causing compressive and/or cosmetic symptoms who are requesting treatment,
* Biopsy-proven indeterminate nodules (AUS or follicular neoplasm)
* Papillary thyroid carcinoma (PTC) without metastasis
* Locally recurrent thyroid cancer (\< 2 cm).
You may not be if
1. Participants meeting any of the following criteria will be excluded:
2. Participants considered unsuitable for RFA by the treating physician
Clareo Health | Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
